Not that I think Nasdaq is in the cards anytime soon, I don't believe revenue is a strict requirement for listing. A number of biotechs on the Nas with little or no revenue. Different markets and tiers possible on Nas, each with own requirements. A few common ones include min share price (US$4) and minimum market cap (varies).
http://venturelawcorp.com/listing-requirements-nasdaq/
In other news, cookie bandit on the lamb. Anyone you know CM?
https://globalnews.ca/news/4896055/peachland-bakery-thief/